Rapport Therapeutics (RAPP) Non-cash Items (2023 - 2026)
Rapport Therapeutics (RAPP) has 4 years of Non-cash Items data on record, last reported at $2.5 million in Q1 2026.
- On a quarterly basis, Non-cash Items rose 169.52% to $2.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 million, a 169.52% increase, with the full-year FY2025 number at $2.0 million, down 94.07% from a year prior.
- Non-cash Items reached $2.5 million in Q1 2026 per RAPP's latest filing, down from $113.8 million in the prior quarter.
- Over the last five years, Non-cash Items for RAPP hit a ceiling of $113.8 million in Q4 2025 and a floor of $914448.0 in Q1 2025.
- A 4-year average of $43.1 million and a median of $34.3 million in 2024 define the central range for Non-cash Items.
- Peak YoY movement for Non-cash Items: soared 449.27% in 2024, then plummeted 70.77% in 2025.
- Tracing RAPP's Non-cash Items over 4 years: stood at $6.2 million in 2023, then skyrocketed by 449.27% to $34.3 million in 2024, then surged by 231.66% to $113.8 million in 2025, then plummeted by 97.84% to $2.5 million in 2026.
- Business Quant data shows Non-cash Items for RAPP at $2.5 million in Q1 2026, $113.8 million in Q4 2025, and $112.4 million in Q3 2025.